173 related articles for article (PubMed ID: 14770094)
1. Comorbid conditions in patients with rheumatic diseases: an update.
Wasko MC
Curr Opin Rheumatol; 2004 Mar; 16(2):109-13. PubMed ID: 14770094
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular co-morbidity in rheumatic diseases.
Turesson C; Jacobsson LT; Matteson EL
Vasc Health Risk Manag; 2008; 4(3):605-14. PubMed ID: 18827910
[TBL] [Abstract][Full Text] [Related]
3. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia.
Wolfe F; Michaud K; Li T; Katz RS
J Rheumatol; 2010 Feb; 37(2):305-15. PubMed ID: 20080915
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Consequences of Autoimmune Rheumatic Diseases.
Atzeni F; Nucera V; Gerratana E; Fiorenza A; Gianturco L; Corda M; Sarzi-Puttini P
Curr Vasc Pharmacol; 2020; 18(6):566-579. PubMed ID: 31985379
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity in rheumatoid arthritis.
Turesson C
Swiss Med Wkly; 2016; 146():w14290. PubMed ID: 27045333
[TBL] [Abstract][Full Text] [Related]
6. Sex-Specific Cardiovascular Comorbidities with Associations in Dermatologic and Rheumatic Disorders.
Kerkhof PLM; Khamaganova I
Adv Exp Med Biol; 2018; 1065():489-509. PubMed ID: 30051403
[TBL] [Abstract][Full Text] [Related]
7. [Rheumatic diseases as risk factors for cardiovascular disease].
Nurmohamed MT; Voskuyl AE; van der Horst-Bruinsma IE; Dijkmans BA
Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1921-4. PubMed ID: 16999275
[TBL] [Abstract][Full Text] [Related]
8. Co-morbidity in rheumatoid arthritis.
Mikuls TR
Best Pract Res Clin Rheumatol; 2003 Oct; 17(5):729-52. PubMed ID: 12915155
[TBL] [Abstract][Full Text] [Related]
9. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.
Wang HL; Zhou YM; Zhu GZ; Yang Z; Hua BJ
Clin Rheumatol; 2018 Jan; 37(1):81-85. PubMed ID: 28508950
[TBL] [Abstract][Full Text] [Related]
10. [Frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases].
Bertin P
Presse Med; 2006 Sep; 35 Suppl 1():5-9. PubMed ID: 17870548
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular co-morbidity in patients with rheumatic diseases.
Frostegård J
Arthritis Res Ther; 2011 Jun; 13(3):225. PubMed ID: 21722331
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
Kitas GD; Dimitroulas T
Int J Rheum Dis; 2021 Apr; 24(4):473-476. PubMed ID: 33817989
[No Abstract] [Full Text] [Related]
13. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.
Gabriel SE; Michaud K
Arthritis Res Ther; 2009; 11(3):229. PubMed ID: 19519924
[TBL] [Abstract][Full Text] [Related]
14. The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.
Schiff MH; DiVittorio G; Tesser J; Fleischmann R; Schechtman J; Hartman S; Liu T; Solinger AM
Arthritis Rheum; 2004 Jun; 50(6):1752-60. PubMed ID: 15188350
[TBL] [Abstract][Full Text] [Related]
15. [What is the frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases?].
Bertin P
Presse Med; 2006 Sep; 35(9 Spec No 1):1S5-9. PubMed ID: 17078590
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities in rheumatoid arthritis.
Michaud K; Wolfe F
Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):885-906. PubMed ID: 17870034
[TBL] [Abstract][Full Text] [Related]
17. Patient survival and safety with biologic therapy. Results of the Mexican National Registry Biobadamex 1.0.
Ventura-Ríos L; Bañuelos-Ramírez D; Hernández-Quiroz Mdel C; Robles-San Román M; Irazoque-Palazuelos F; Goycochea-Robles MV
Reumatol Clin; 2012; 8(4):189-94. PubMed ID: 22673388
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular involvement in rheumatic diseases].
Driazhenko IV
Kardiologiia; 2005; 45(11):98-104. PubMed ID: 16353072
[TBL] [Abstract][Full Text] [Related]
19. Malignancy and autoimmunity.
Bernatsky S; Ramsey-Goldman R; Clarke A
Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
[TBL] [Abstract][Full Text] [Related]
20. Managing comorbidity risks in rheumatoid arthritis.
Dechant SA; Matteson EL
Curr Opin Rheumatol; 2004 May; 16(3):177-9. PubMed ID: 15103241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
